SCHEMBL16085116

SCHEMBL16085116

C[C@@H]1CC(S(C)(=O)=O)CCN1C

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26187138 0.82 ACHE (0.33) ACHE
Hydrochloric Acid SCHEMBL27748361 0.80 ACHE (0.32) ACHE
SCHEMBL15443394 0.78 ACHE (0.32) ACHE
SCHEMBL22299163 0.78 ACHE (0.32) ACHE
SCHEMBL14985729 0.78 ACHE (0.32) ACHE
SCHEMBL22299304 0.78 ACHE (0.32) ACHE
SCHEMBL17450325 0.75 ACHE (0.31) ACHE
SCHEMBL14968373 0.75 ACHE (0.31) ACHE
SCHEMBL14962471 0.71 PIK3CD (0.34)
SCHEMBL357188 0.70 NCF1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970323-B1 FUROPYRIDINES AS BROMODOMAIN INHIBITORS. GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD (GB) 2017-10-18 EP disclosed
US-9670221-B2 Furopyridines as bromodomain inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED (GB) 2017-06-06 US disclosed
WO-2014140077-A1 FUROPYRIDINES AS BROMODOMAIN INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2014-09-18 WO disclosed